Rivator 1 mg (Pitavastatin Calcium Hydrate)
Pitavastatin Calcium Hydrate 1.102mg
Tablet · Prescription medication
Boryung Biopharma Co., Ltd.
MFDS item code 202102838 · Approved 2021.04.01
Improvement of hypercholesterolemia (including pediatric familial hypercholesterolemia, etc.) and mixed dyslipidemia
This medication is a dietary supplement developed for patients with hypercholesterolemia and dyslipidemia. It primarily lowers total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels while raising HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It is especially effective for pediatric patients aged 10 to 16 with heterozygous familial hypercholesterolemia. It is used in children when the LDL cholesterol levels are above certain thresholds, there is a family history of early cardiovascular disease, or other risk factors are present. This medication helps reduce the risk of cardiovascular diseases as an adjunct to dietary therapy. Therefore, it is used to improve cholesterol management and enhance cardiovascular health.
Patients receiving this medicine must follow a standard cholesterol-lowering diet before and during treatment. 1. As an adjunct to diet to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B, and triglyceride levels and to increase HDL cholesterol in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial, Fredrickson type IIa) and mixed dyslipidemia (Fredrickson type IIb) The usual initial dose in adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg once daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response. The therapeutic effect of this medicine is maintained with continued use.
Ages 10 ~ 16: Take 1 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 2 mg once daily.
This medication should not be used in patients who have had allergic reactions to specific components or those with active liver disease or persistent liver function abnormalities. Patients with severe liver dysfunction or bile duct obstruction, those taking cyclosporine, patients with myopathy, pregnant women, or nursing mothers should also avoid using this drug. This medication contains lactose, so patients with lactose intolerance or related genetic disorders should avoid taking it. Patients with kidney dysfunction, liver dysfunction, those who consume alcohol excessively, elderly patients, and children should use this medication with greater caution. This medication may cause side effects such as myalgia, muscle weakness, liver function abnormalities, and thrombocytopenia; thus, if any abnormal symptoms occur, immediate consultation with a physician is required. During administration, regular liver function tests and blood lipid assays should be conducted, and if there is no therapeutic effect, discontinuation of use should be considered. This medication may interact with other specific drugs, potentially leading to impaired kidney function or muscle damage, so consultation with a specialist is recommended when used concurrently. Pregnant or nursing women should not take this drug, and if pregnant, should immediately discontinue use and consult a doctor. In children, this medication should be administered cautiously under the guidance of a physician experienced in treating familial hypercholesterolemia, as safety in children under 10 years has not been established. Store out of reach of children and keep in the original container to prevent degradation of quality or misuse. This medication is used for the treatment of hypercholesterolemia, and non-pharmacological treatments such as dietary therapy and exercise should be considered first before administration. Rare cases of interstitial lung disease or increased risk of diabetes may occur with long-term use, so regular health monitoring is necessary. This medication requires caution regarding muscle-related adverse reactions, and if symptoms like myalgia or weakness occur, discontinuation of use should be immediate, followed by consultation with healthcare professionals.
Abdominal pain, rash, fatigue, paralysis, itching, increased γ-GT, elevated plasma creatine phosphokinase level, elevated serum ALT, elevated serum AST, headache, myalgia, weakness, elevated CPK, increased myoglobin in blood and urine, liver dysfunction, jaundice, thrombocytopenia, urticaria, erythema, angioedema, increased bilirubin, elevated cholinesterase, increased ALP, increased LDH, stiffness, drowsiness, insomnia, feeling of heaviness, dizziness, thirst, dyspepsia, abdominal bloating, constipation, stomatitis, vomiting, loss of appetite, glossitis, nausea, gastrointestinal discomfort, diarrhea, decreased granulocytes, leukopenia, increased eosinophils, leukocytosis, elevated globulin, positive Coombs test, anemia, polyuria, increased BUN, elevated serum creatinine, decreased aldosterone, increased aldosterone, increased adrenocorticotropic hormone, elevated cortisol, decreased testosterone, muscle cramps, palpitations, fatigue, skin pain, burning sensation, arthralgia, edema, blurred vision, photophobia, hearing loss, hematuria, increased uric acid level, elevated serum potassium and phosphorus, dysgeusia, discolored urine, fatigue, positive antinuclear antibodies, hair loss, sleep disturbance, memory loss, depression, interstitial lung disease, sexual dysfunction, diabetes, immune-mediated necrotizing myopathy, myasthenia gravis, ocular myasthenia, facial edema, arm edema, hypersensitivity, skin paresthesia, loss of appetite, increased blood pressure, chest discomfort, weakness, nausea, thrombocytopenia, increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that protects it from light, as it is sensitive to light. Additionally, it is best to store the medication at room temperature, ideally between 1 to 30 degrees Celsius, avoiding places that are too hot or too cold. Storing it this way helps maintain the medication's efficacy.
White round film-coated tablet
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Pitavastatin Calcium Hydrate 1.102mg
Tablet · Prescription medication
Boryung Biopharma Co., Ltd.

Pitavastatin Calcium Hydrate 1mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Pitavastatin Calcium Hydrate 2mg
Tablet · Prescription medication
JW Pharmaceutical Corporation
Pitavastatin Calcium 2mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Pitavastatin Calcium 2mg
Tablet · Prescription medication
Samchundang Pharmaceutical Co., Ltd.

Pitavastatin Calcium 2mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Pitavastatin Calcium 2mg
Tablet · Prescription medication
Samnam Pharmaceutical Co., Ltd.

Pitavastatin Calcium 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.